600222.SS · 太龙药业
China A-shares · RS rating 62 · As of 2026-10-14
| Price | 7.21 CNY |
|---|---|
| 1-day change | -4.8% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 16 / 46 / 80 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 37 / 12 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +10.7% |
| Distance from 52-week high | +19.4% |
| Market cap (USD) | $637.4M |